Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 207,537 | 79,449 | 82,673 | 62,936 | 39,661 |
| Marketable Securities | 379,713 | 335,907 | 396,717 | 415,667 | 445,820 |
| TOTAL | $604,785 | $430,031 | $494,377 | $495,981 | $499,533 |
| Non-Current Assets | |||||
| PPE Net | 45,452 | 46,732 | 47,481 | 47,195 | 36,955 |
| Investments And Advances | 9,684 | 39,886 | 23,534 | 55,832 | 97,554 |
| Other Non-Current Assets | 35,944 | 36,582 | 37,586 | 38,596 | 42,554 |
| TOTAL | $91,080 | $123,200 | $108,601 | $141,623 | $177,063 |
| Total Assets | $695,865 | $553,231 | $602,978 | $637,604 | $676,596 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,316 | 2,590 | 2,022 | 3,931 | 3,662 |
| Accrued Expenses | 5,349 | N/A | 15,467 | 13,793 | 12,114 |
| Other current liabilities | 35,849 | 42,754 | 29,196 | 28,825 | 27,468 |
| TOTAL | $47,635 | $45,344 | $46,685 | $46,549 | $43,244 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 102,919 | 112,997 | 118,096 | 115,882 | 116,704 |
| TOTAL | $102,919 | $112,997 | $118,096 | $115,882 | $116,704 |
| Total Liabilities | $150,554 | $158,341 | $164,781 | $162,431 | $159,948 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,628 | 105,423 | 96,031 | 95,842 | 95,478 |
| Common Shares | 1,382 | 1,288 | 1,286 | 1,283 | 1,279 |
| Retained earnings | -482,314 | -425,551 | -371,526 | -325,266 | -266,929 |
| Other shareholders' equity | 835 | 350 | 562 | 879 | 332 |
| TOTAL | $545,311 | $394,890 | $438,197 | $475,173 | $516,648 |
| Total Liabilities And Equity | $695,865 | $553,231 | $602,978 | $637,604 | $676,596 |